Management of Pump Thrombosis in Patients with Left Ventricular Assist Devices

American Journal of Cardiovascular Drugs

Volumn 15, Issue 2, 2015, Pages 89-94

  Stulak, John M ^a   Sharma, Shashank ^a   Maltais, Simon ^b  

^a Mayo Clinic   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; DISEASE MANAGEMENT; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HUMAN; RETROSPECTIVE STUDY; THERAPY; THROMBOSIS;

DISEASE MANAGEMENT; HEART-ASSIST DEVICES; HUMANS; RETROSPECTIVE STUDIES; THROMBOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84939969295     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.1007/s40256-014-0102-3     Document Type: Article

References (33)

1. Kirklin JK, Naftel DC, Warner-Stevenson L, et al. INTERMACS database for durable devices for circulatory support. First annual report. J Heart Lung Transplant. 2008;27(10):1065–72.
2. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29(1):1–10.
3. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115–23.
4. Kirklin JK, Naftel DC, Kormos RL, et al. The Fourth INTERMACS annual report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31(2):117–26.
5. Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141–56.
6. Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: a 10,000 patient database. J Heart Lung Transplant. 2014;33(6):555–64.
7. Park SJ, Milano CA, Tatooles AJ, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241–8.
8. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40.
9. Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22.
10. Slaughter MS, Naka Y, John R, et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant. 2010;29:616–24.
11. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.
12. Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombosis events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol. J Heart Lung Transplant. 2014;33:23–34.
13. Slaughter MS, Pagani FD, McGee EC, et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2013;32:675–83.
14. Stulak JM, Lee D, Haft JW, et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. J Heart Lung Transplant. 2014;33:60–4.
15. Wever-Pinzon O, Selzman CH, Drakos SG, et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail. 2013;6:517–26.
16. Saceed O, Maybaum S, D’Alessandro D, Goldstein DJ, Patel SR. Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2014;33:109–11.
17. Meyer AL, Malesha D, Bara C, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circulation. 2010;3:675–81.
18. Morgan JA, Paone G, Nemeh HW, et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2012;31:715–8.
19. Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51–9.
20. Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA. Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg. 2013;32:S38–9.
21. Goldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013;32:667–70.
22. Cowger JA, Romano MA, Shah P, et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J Heart Lung Transplant. 2014;2014(33):35–43.
23. Schlendorf K, Patel CB, Gehrig T, et al. Thrombolytic therapy for thrombosis of continuous flow ventricular assists devices. J Card Fail. 2014;20(2):91–7.
24. Al-Quthami M, Jumean R, Kociol R, et al. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis. Circ Heart Fail. 2012;5:e68–70.
25. Tellor JR, Smith SM, Prasad SM, et al. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. J Heart Lung Transplant. 2014;33:94–101.
26. Kamouth A, John R, Eckman P. Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics. Ann Thorac Surg. 2012;94(1):281–3.
27. Lenneman P, Combs S, Rhode K, et al. Management and outcomes of ventricular assist device patients with suspected pump thrombosis. J Heart Lung Transplant. 2013;32(4):S186–7.
28. Ota H, Yerebakan H, Akashi H, et al. Continuous-flow left ventricular assist device exchange: clinical outcomes. J Heart Lung Transplant. 2014;33:65–70.
29. Moazami N, Milano CA, John R, et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg. 2013;95:500–5.
30. Stulak JM, Cowger J, Haft HW, Romano MA, Aaronson KD, Pagani FD. Device exchange after primary left ventricular assist device implantation. Ann Thorac Surg. 2013;95(4):1262–7.
31. Rojas SV, Avsar M, Khalpey Z, Hanke JS, Haverich A, Schmitto JD. Minimally-invasive off-pump left ventricular assist device exchange: anterolateral thoracotomy. Artif Organs. 2014;38(7):539–42.
32. Stulak JM, Maltais S. A different perspective on thrombosis and the HeartMate II. N Engl J Med. 2014;370:1467–8.
33. Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant. 2014;33:1–11.